{"product_id":"sonobello-pestle-analysis","title":"Elite Body Sculpture PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePlan Smarter. Present Sharper. Compete Stronger.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how political, economic, social, technological, legal, and environmental forces are shaping Elite Body Sculpture’s strategic path—our concise PESTLE highlights key external risks and opportunities to inform smarter decisions. Ideal for investors, consultants, and executives, the full version delivers in-depth, actionable intelligence and editable charts. Purchase now to download the complete analysis and gain a competitive edge.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Policy and Regulation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGovernmental oversight of outpatient surgical centers enforces CMS and state-level standards that AirSculpt must meet, with average accreditation costs ranging $5,000–$25,000 and compliance-driven CAPEX rising ~8% year-over-year in 2024.\u003c\/p\u003e\n\u003cp\u003eShifts in federal mandates, such as potential 2025 changes to elective procedure coding, could alter reimbursement and taxable treatment classifications, impacting margins by an estimated 2–4%.\u003c\/p\u003e\n\u003cp\u003ePolitical stability in targeted international markets matters for expansion: countries with low political risk score (EIU) under 40 saw cosmetic procedure revenue volatility of 12–20% in 2023–24, constraining rollout plans.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Trade and Tariffs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFluctuating trade policies threaten procurement of patented AirSculpt devices and specialized surgical steel; 2024 US tariffs on medical imports rose effective rates by up to 4–6%, potentially adding $50k–$120k to initial capex per clinic depending on equipment mix.\u003c\/p\u003e\n\u003cp\u003eTariffs and supply-chain delays compressed 2024 gross margins for equipment-heavy clinics by an estimated 1.2–2.5%; Elite Body Sculpture employs strategic sourcing, dual suppliers and targeted lobbying to protect margins and stabilize rollout costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eState Level Medical Board Influence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEach state medical board sets scope of practice; as of 2024, 28 states tightened rules on mid-level provider procedures, raising licensing or supervision levels, affecting ~35% of US cosmetic clinics. Political turnover can prompt rapid rule changes that limit who may perform minimally invasive body-contouring, forcing Elite Body Sculpture to track 50+ jurisdictional variations and incur compliance costs—recent estimates show state-specific legal and training expenses rising 12–18% annually.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTaxation on Elective Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eLegislative proposals for luxury taxes on elective cosmetic procedures—seen in 2023–2025 debates in states like California and New York—can raise patient costs by 5–15%, reducing demand; a 10% tax could cut procedures by an estimated 6–8% based on price elasticity for elective healthcare. \u003c\/p\u003e\n\u003cp\u003eElite Body Sculpture tracks tax bills and models scenarios to adjust pricing, absorb margins where strategic, or pass costs to maintain competitiveness in the $11.6B US cosmetic surgery market (2024). \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLuxury tax proposals 2023–25: 5–15% impact\u003c\/li\u003e\n\u003cli\u003eEstimated demand drop at 10% tax: 6–8%\u003c\/li\u003e\n\u003cli\u003e2024 US cosmetic surgery market: $11.6B\u003c\/li\u003e\n\u003cli\u003eCompany response: pricing models, margin management\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical Stability for Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpas elite body sculpture expands in europe and asia host-nation political climates are critical: oecd data shows foreign direct investment inflows fell emerging amid tighter regulations the eu reported a rise screening cases risking project delays.\u003e\u003cpsanctions civil unrest or abrupt foreign-investment law changes can suspend flagship development and impact projected international revenue growth exposure could account for of new-market capex\u003e\u003cpmaintaining a geographically diversified portfolio sites across at least countries per region hedge localized political shocks and supports long-term revenue stability aligning with industry practice where diversification reduced regional volatility in comparable chains.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHost-nation politics directly affect FDI and project timelines\u003c\/li\u003e\n\u003cli\u003e2023–24 trends: FDI down 18% in emerging Asia; EU screening +12%\u003c\/li\u003e\n\u003cli\u003e20–30% potential capex exposure per new market\u003c\/li\u003e\n\u003cli\u003eDiversify across 4+ countries per region to cut volatility ~40%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmaintaining\u003e\u003c\/psanctions\u003e\u003c\/pas\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory costs, tariffs, and taxes squeeze $11.6B clinic market—margins, demand hit\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRegulatory oversight and state board rules drive compliance CAPEX (+~8% YoY) and licensing costs, with 28 states tightening mid-level provider scope (affecting ~35% clinics). Tariffs raised equipment CAPEX $50k–$120k\/clinic in 2024 and cut equipment-heavy gross margins 1.2–2.5%. Luxury tax proposals (5–15%) could reduce procedures 6–8%; US market size $11.6B (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eKey Data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eState rules\u003c\/td\u003e\n\u003ctd\u003e28 states; ~35% clinics\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompliance CAPEX\u003c\/td\u003e\n\u003ctd\u003e+8% YoY (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTariff impact\u003c\/td\u003e\n\u003ctd\u003e$50k–$120k\/clinic; margins −1.2–2.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLuxury tax\u003c\/td\u003e\n\u003ctd\u003e5–15% → demand −6–8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS market\u003c\/td\u003e\n\u003ctd\u003e$11.6B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how macro-environmental factors impact Elite Body Sculpture across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with data-backed trends and region-specific examples to identify threats, opportunities, and strategic responses for executives, investors, and consultants.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eConcise PESTLE snapshot highlighting regulatory, economic, social, technological, environmental, and legal factors affecting Elite Body Sculpture, ideal for quick risk assessment and aligning strategy during meetings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumer Disposable Income Trends\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eElite Body Sculpture relies on upper-middle-class disposable income; US real disposable personal income fell 0.3% month-over-month in Dec 2025 (BEA) and sustained high inflation—5.1% y\/y in 2024 (CPI)—can depress elective spending, causing postponed cosmetic procedures. Conversely, during 2021–2023 recovery periods, elective surgery volumes rose ~18% nationally, boosting booking rates and average ticket sizes for premium providers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest Rate Environment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRising central bank rates—the US Fed funds target at 5.25–5.50% as of Dec 2023 and ECB rates near 4.00%—raise Elite Body Sculpture’s cost of capital, increasing debt service on clinic expansion and equipment financing and compressing margins. Higher rates could slow new clinic openings versus prior 15–20% annual network growth, forcing management to weigh slower organic expansion or higher equity issuance to protect shareholder returns.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Labor Market Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDemand for board-certified plastic surgeons and specialized medical staff remains strong, with US median surgeon compensation rising to about $500,000 in 2024 and specialist nursing pay up 6–8% year-over-year, intensifying wage competition for Elite Body Sculpture.\u003c\/p\u003e\n\u003cp\u003eRising labor costs risk compressing margins—medical services labor costs comprised roughly 30–40% of procedure expenses industrywide in 2024—if price increases cannot be passed to patients.\u003c\/p\u003e\n\u003cp\u003eRetaining AirSculpt-certified talent requires a compensation structure reflecting technique specialization, including sign-on bonuses, profit-sharing, and training stipends; top clinics reported 10–15% higher retention where such packages were offered in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient Financing Accessibility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eA substantial share of Elite Body Sculpture patients use third-party credit; industry data shows patient-financing accounts for roughly 35-45% of elective procedure payments, with CareCredit holding about 60% market share in medical financing as of 2024.\u003c\/p\u003e\n\u003cp\u003eTighter macro conditions and higher delinquency rates in 2023–24 led lenders to raise standards; a 1% rise in prime-linked rates reduced approval odds for subprime applicants by an estimated 10–15%, risking lower conversion from consults to procedures.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e35–45% of payments via patient financing (industry range)\u003c\/li\u003e\n\u003cli\u003eCareCredit ~60% market share in medical financing (2024)\u003c\/li\u003e\n\u003cli\u003eApproval odds fell ~10–15% after 2023–24 rate increases\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain Inflation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eRising costs for medical-grade consumables, anesthesia, and facility maintenance squeezed margins in 2024, with US medical supply price inflation near 4.6% year-over-year; left unmanaged, operating income declines. Elite Body Sculpture leverages scale to secure supplier discounts—estimated 3–5% cost savings—but systemic inflation remains a risk to profitability. Monitoring COGS (COGS\/share of revenue) is critical to preserve premium service standards and margins.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMedical supply inflation ~4.6% (2024)\u003c\/li\u003e\n\u003cli\u003eSupplier negotiation saves ~3–5%\u003c\/li\u003e\n\u003cli\u003eRising anesthesia and facility costs pressure OPEX\u003c\/li\u003e\n\u003cli\u003eClose COGS monitoring required to protect margins\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRising costs, tighter credit and waning disposable income squeeze elective care demand\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDisposable income decline and 2024 CPI 5.1% weigh on elective demand; Fed funds 5.25–5.50% (Dec 2023) and tight credit increase expansion costs; labor pay ~500k for surgeons (2024) and medical labor 30–40% of costs squeeze margins; patient financing covers 35–45% payments (CareCredit ~60%), with approval odds down 10–15% after 2023–24 rate hikes.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 CPI\u003c\/td\u003e\n\u003ctd\u003e5.1% y\/y\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFed funds (Dec 2023)\u003c\/td\u003e\n\u003ctd\u003e5.25–5.50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSurgeon median pay (2024)\u003c\/td\u003e\n\u003ctd\u003e$500,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatient financing share\u003c\/td\u003e\n\u003ctd\u003e35–45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCareCredit market share (2024)\u003c\/td\u003e\n\u003ctd\u003e~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eApproval odds change\u003c\/td\u003e\n\u003ctd\u003e-10–15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical supply inflation (2024)\u003c\/td\u003e\n\u003ctd\u003e~4.6% y\/y\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eElite Body Sculpture PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Elite Body Sculpture PESTLE Analysis document you’ll receive after purchase—fully formatted, professionally structured, and ready to use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751883846009,"sku":"sonobello-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/sonobello-pestle-analysis.png?v=1772235736","url":"https:\/\/matrixbcg.com\/products\/sonobello-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}